BCRX: BioCryst Pharmaceuticals, Inc. Kompaniya qiymatining sof foydaga nisbati
BioCryst yuqori rahbariyati biznesni tadqiqot bosqichidan tijorat sektoriga professional tarzda o'tkazdi va patent himoyasini ta'minladi. P/E baholash koeffitsiyenti bozor qiymatini haqiqiy foyda bilan aniq bog'laydi, -5.50 esa parametrning joriy holatini aks ettiradi. John Stonehouse dori vositalari savdosini samarali kengaytirmoqda va pul oqimlarini optimallashtirmoqda. Ekologik siyosat qat'iy chiqindilarni yo'q qilish nazorati va energiya auditlariga asoslangan.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_BCRX_-_BioCryst_-_PE-Multiple "BCRX: BioCryst Biznesning o‘zini qoplash muddati 04.07.2022 - 10.11.2026 | 👁️GURU.Markets👁️")
BioCryst Pharmaceuticals Inc (BCRX) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati BioCryst|BCRX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati BioCryst Corp|BCRX - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati BioCryst Pharmaceuticals|BCRX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz BioCryst|Tezkor likvidlik biocryst.com
- foyda va bozor multiplikatorlari tafsilotlari:
BCRX - Sof foyda|Kompaniya foydasi prognozi BioCryst|BCRX - Narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati BioCryst Pharmaceuticals, Inc.|BCRX - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti BioCryst Pharmaceuticals|BCRX - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda BioCryst|BCRX - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi biocryst.com|BCRX - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi BioCryst
Kompaniyaning har tomonlama tahlili:biocryst.com BCRX
BioCryst (BCRX) uchun, raqobatlashish qobiliyati innovatsion dori dizayni va Orladeyo muvaffaqiyatiga asoslangan holda, kompaniyaning -5.50 miqdoridagi kutilayotgan P/E ko'rsatkichi joriy aksiya narxiga nisbatan kelajakdagi daromadlarning bozor bahosini aks ettiradi. Ushbu ko'rsatkich investitsiyalarning qoplanish muddatini belgilaydi, bunda pastroq raqamlar aktivning qadrsizlanganini va bozorning stress-testlari paytida xavfsizlikning yuqori darajasini anglatadi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati Vera Therapeutics, Inc. (VERA)|dianthustx.com - Narx-foyda multiplikatori|P/E multiplikatori PHVS (Pharvaris)|AbCellera Corp (ABCL) - Kapitalizatsiyaning foydaga nisbati|Tourmaline Corp - P/E multiplikatori|PGEN: Narxning foydaga nisbati|PHAR: P/E multiplikatori|NKTR - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Upstream Bio|Kapitalizatsiyaning foydaga nisbati Zenas Bio ZBIO|P/E multiplikatori IMNM|Narx-foyda koeffitsiyenti Gossamer Bio Corp. GOSS|Narxning foydaga nisbati KalVista Pharmaceuticals KALV|Kompaniya qiymatining sof foydaga nisbati SEPN|PVLA: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Savara Inc|Rigel Pharmaceuticals Inc (RIGL) - Narxning foydaga nisbati|ANAB - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ATXS|ENGN (engene.com) - Bozor narxining sof foydaga nisbati|P/E multiplikatori RAPT|Narxning foydaga nisbati JBIO (aerovatetx.com)|P/E multiplikatori ACRS (Aclaris)|KYTX - Narx-foyda koeffitsiyenti|TLSA - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati CABA (cabalettabio.com)|VTYX (Ventyx Biosciences, Inc.) - Narx-foyda koeffitsiyenti|Narx-foyda multiplikatori THTX|Narxning foydaga nisbati Avalo Therapeutics Inc.|Eledon Pharmaceuticals, Inc - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori AGEN|CLYM (climbbio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ZURA (Zura Bio)|P/E multiplikatori aTyr Pharma Inc ATYR|ADAG - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati IMA (ImageneBio Inc)|shattucklabs.com (STTK) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Equillium|CNTB (Connect Biopharma Holdings) - P/E multiplikatori|P/E multiplikatori Immunic Inc|Narx-foyda koeffitsiyenti ATRA (Atara Biotherapeutics)|IFRX (inflarx.de) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori XFOR (X4 Pharmaceuticals)|Biznesning o‘zini qoplash muddati Adicet Bio Inc. (ACET)|CELU - Narxning foydaga nisbati|INmune Bio Inc (INMB) - Narx-foyda koeffitsiyenti|Barinthus Bio (BRNS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Kezar Life Sciences Inc|Narx-foyda koeffitsiyenti SABS|P/E multiplikatori akaritx.com|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|q32bio.com - Narx-foyda multiplikatori|P/E multiplikatori GOVX (GeoVax Labs Inc)|Edesa Biotech Corp (EDSA) - Kapitalizatsiyaning foydaga nisbati|iBio, Inc. - P/E multiplikatori|CARM: Narxning foydaga nisbati|XTLB: P/E multiplikatori|BOLT - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati HCW Biologics, Inc.|Kapitalizatsiyaning foydaga nisbati Aptevo APVO|P/E multiplikatori AIM|Narx-foyda koeffitsiyenti aditxt.com ADTX|Narxning foydaga nisbati GRI Bio GRI|Kompaniya qiymatining sof foydaga nisbati XRTX|HIND: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Revelation Biosciences Corp|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|SCNI - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti CALI|AFMD (Affimed Therapeutics) - Bozor narxining sof foydaga nisbati|P/E multiplikatori ALLK|Narxning foydaga nisbati HOOK (hookipapharma.com)|P/E multiplikatori IGMS (IGM Biosciences)|ITOS - Narx-foyda koeffitsiyenti|OCEA - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) Plc)|THRD (Third Harmonic Bio, Inc) - Narx-foyda koeffitsiyenti
